Aviv Reisfeld
Direktor/Vorstandsmitglied bei Medifreeze Ltd.
Profil
Aviv Reisfeld is currently a Director at Medifreeze Ltd.
and also holds the position of General Counsel at Hadasit Medical Research Services & Development Ltd.
He previously worked as a Director at HBL- Hadasit Bio-Holdings Ltd.
from 2018 to 2021.
Mr. Reisfeld has a graduate degree from the University of Warwick and an MBA from Bar-Ilan University.
Aktive Positionen von Aviv Reisfeld
| Unternehmen | Position | Beginn |
|---|---|---|
| Medifreeze Ltd. | Direktor/Vorstandsmitglied | - |
Hadasit Medical Research Services & Development Ltd.
 Hadasit Medical Research Services & Development Ltd. Miscellaneous Commercial ServicesCommercial Services Hadasit Medical Research Services & Development Ltd. operates as technology transfer company of Hadassah Medical Center in Jerusalem. It identifies, protects, nurtures and commercializes the discoveries made at Hadassah Medical Center. The company's product include Doxil, Periochip, Travelan, Granagard, and Insupad. The company was founded on December 7, 1986 and is headquartered in Jerusalem, Israel. | General Counsel | 01.11.2007 |
Ehemalige bekannte Positionen von Aviv Reisfeld
| Unternehmen | Position | Ende |
|---|---|---|
| HBL - HADASIT BIO-HOLDINGS LTD | Direktor/Vorstandsmitglied | 29.03.2021 |
Ausbildung von Aviv Reisfeld
| University of Warwick | Graduate Degree |
| Bar-Ilan University | Masters Business Admin |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 1 |
|---|---|
| HBL - HADASIT BIO-HOLDINGS LTD | Finance |
| Private Unternehmen | 2 |
|---|---|
Hadasit Medical Research Services & Development Ltd.
Hadasit Medical Research Services & Development Ltd. Miscellaneous Commercial ServicesCommercial Services Hadasit Medical Research Services & Development Ltd. operates as technology transfer company of Hadassah Medical Center in Jerusalem. It identifies, protects, nurtures and commercializes the discoveries made at Hadassah Medical Center. The company's product include Doxil, Periochip, Travelan, Granagard, and Insupad. The company was founded on December 7, 1986 and is headquartered in Jerusalem, Israel. | Commercial Services |
| Medifreeze Ltd. |
